BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 37775001)

  • 1. Adipocyte-derived exosomes promote the progression of triple-negative breast cancer through circCRIM1-dependent OGA activation.
    Li Y; Jiang B; Zeng L; Tang Y; Qi X; Wan Z; Feng W; Xie L; He R; Zhu H; Wu Y
    Environ Res; 2023 Dec; 239(Pt 1):117266. PubMed ID: 37775001
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LncRNA HAND2-AS1 suppressed the growth of triple negative breast cancer via reducing secretion of MSCs derived exosomal miR-106a-5p.
    Xing L; Tang X; Wu K; Huang X; Yi Y; Huan J
    Aging (Albany NY); 2020 Dec; 13(1):424-436. PubMed ID: 33290256
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor-derived exosomal circPSMA1 facilitates the tumorigenesis, metastasis, and migration in triple-negative breast cancer (TNBC) through miR-637/Akt1/β-catenin (cyclin D1) axis.
    Yang SJ; Wang DD; Zhong SL; Chen WQ; Wang FL; Zhang J; Xu WX; Xu D; Zhang Q; Li J; Zhang HD; Hou JC; Mao L; Tang JH
    Cell Death Dis; 2021 Apr; 12(5):420. PubMed ID: 33911067
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MiR-6838-5p suppresses cell metastasis and the EMT process in triple-negative breast cancer by targeting WNT3A to inhibit the Wnt pathway.
    Liu G; Wang P; Zhang H
    J Gene Med; 2019 Dec; 21(12):e3129. PubMed ID: 31693779
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The circRNA circAGFG1 acts as a sponge of miR-195-5p to promote triple-negative breast cancer progression through regulating CCNE1 expression.
    Yang R; Xing L; Zheng X; Sun Y; Wang X; Chen J
    Mol Cancer; 2019 Jan; 18(1):4. PubMed ID: 30621700
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cancer cell-derived exosomal miR-20a-5p inhibits CD8
    Li W; Han G; Li F; Bu P; Hao Y; Huang L; Bai X
    Cancer Sci; 2024 Feb; 115(2):347-356. PubMed ID: 38129137
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hsa_circRNA_102229 facilitates the progression of triple-negative breast cancer via regulating the miR-152-3p/PFTK1 pathway.
    Du C; Zhang J; Zhang L; Zhang Y; Wang Y; Li J
    J Gene Med; 2021 Sep; 23(9):e3365. PubMed ID: 34031947
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Docetaxel-resistant triple-negative breast cancer cell-derived exosomal lncRNA LINC00667 reduces the chemosensitivity of breast cancer cells to docetaxel via targeting miR-200b-3p/Bcl-2 axis.
    Li J; Kang J; Liu W; Liu J; Pan G; Mao A; Zhang Q; Lu J; Ding J; Li H
    Eur J Histochem; 2022 Oct; 66(4):. PubMed ID: 36281649
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-211-5p suppresses tumour cell proliferation, invasion, migration and metastasis in triple-negative breast cancer by directly targeting SETBP1.
    Chen LL; Zhang ZJ; Yi ZB; Li JJ
    Br J Cancer; 2017 Jun; 117(1):78-88. PubMed ID: 28571042
    [TBL] [Abstract][Full Text] [Related]  

  • 10. miR-374a-5p promotes tumor progression by targeting ARRB1 in triple negative breast cancer.
    Son D; Kim Y; Lim S; Kang HG; Kim DH; Park JW; Cheong W; Kong HK; Han W; Park WY; Chun KH; Park JH
    Cancer Lett; 2019 Jul; 454():224-233. PubMed ID: 31004703
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Engineered Exosomes Carrying miR-588 for Treatment of Triple Negative Breast Cancer Through Remodeling the Immunosuppressive Microenvironment.
    Zhang Z; Luo X; Xue X; Pang M; Wang X; Yu L; Qian J; Li X; Tian M; Lu A; Lu C; Liu Y
    Int J Nanomedicine; 2024; 19():743-758. PubMed ID: 38283199
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long noncoding RNA ST8SIA6-AS1 promotes cell proliferation and metastasis in triple-negative breast cancer by targeting miR-145-5p/CDCA3 to inactivate the p53/p21 signaling pathway.
    Qiao Y; Wang B; Yan Y; Niu L
    Environ Toxicol; 2022 Oct; 37(10):2398-2411. PubMed ID: 35730485
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The stromal loss of miR-4516 promotes the FOSL1-dependent proliferation and malignancy of triple negative breast cancer.
    Kim JE; Kim BG; Jang Y; Kang S; Lee JH; Cho NH
    Cancer Lett; 2020 Jan; 469():256-265. PubMed ID: 31672492
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CircWAC induces chemotherapeutic resistance in triple-negative breast cancer by targeting miR-142, upregulating WWP1 and activating the PI3K/AKT pathway.
    Wang L; Zhou Y; Jiang L; Lu L; Dai T; Li A; Chen Y; Zhang L
    Mol Cancer; 2021 Mar; 20(1):43. PubMed ID: 33648498
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LncRNA WEE2-AS1 promotes proliferation and inhibits apoptosis in triple negative breast cancer cells via regulating miR-32-5p/TOB1 axis.
    Wang R; Huang Z; Qian C; Wang M; Zheng Y; Jiang R; Yu C
    Biochem Biophys Res Commun; 2020 Jun; 526(4):1005-1012. PubMed ID: 32307083
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CircWHSC1 regulates malignancy and glycolysis by the miR-212-5p/AKT3 pathway in triple-negative breast cancer.
    Ding L; Xie Z
    Exp Mol Pathol; 2021 Dec; 123():104704. PubMed ID: 34624276
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MiR-140-5p inhibits cell proliferation and metastasis by regulating MUC1 via BCL2A1/MAPK pathway in triple negative breast cancer.
    Yu B; You W; Chen G; Yu Y; Yang Q
    Cell Cycle; 2019 Oct; 18(20):2641-2650. PubMed ID: 31411515
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exosomes deliver lncRNA DARS-AS1 siRNA to inhibit chronic unpredictable mild stress-induced TNBC metastasis.
    Liu X; Zhang G; Yu T; He J; Liu J; Chai X; Zhao G; Yin D; Zhang C
    Cancer Lett; 2022 Sep; 543():215781. PubMed ID: 35688263
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LncRNA FAM83H-AS1 promotes triple-negative breast cancer progression by regulating the miR-136-5p/metadherin axis.
    Han C; Fu Y; Zeng N; Yin J; Li Q
    Aging (Albany NY); 2020 Feb; 12(4):3594-3616. PubMed ID: 32074085
    [TBL] [Abstract][Full Text] [Related]  

  • 20. circKIF4A acts as a prognostic factor and mediator to regulate the progression of triple-negative breast cancer.
    Tang H; Huang X; Wang J; Yang L; Kong Y; Gao G; Zhang L; Chen ZS; Xie X
    Mol Cancer; 2019 Feb; 18(1):23. PubMed ID: 30744636
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.